BioSpace News Archive

Business

Leading Medical Device Manufacturers of CE-Marked THV Devices Sign Contracts with ClinFlows

December 12, 2011
·
2 min read
Business

ULURU Inc. Extends the European Altrazeal(R) License to Include Australia and New Zealand

December 12, 2011
·
4 min read
Deals

ICON Acquires BeijingWits Medical Consulting Ltd

December 12, 2011
·
1 min read
BioForest

International Isotopes Announces Conference Call to Give an Update on the Company’s General Business Status

December 12, 2011
·
1 min read
Drug Development

Cornerstone Pharmaceuticals, Inc.’ Cancer Metabolism Inhibitor, CPI-613, Showing Promise in Phase I Trial for Acute Myeloid Leukemia

December 12, 2011
·
4 min read
Drug Development

Isis Pharmaceuticals, Inc. Reports Positive Phase 1 Data Demonstrating ISIS-FXIRx Reduces Factor XI Activity Without Bleeding

December 12, 2011
·
7 min read
Drug Development

CytRx Corporation Announces the Presentation of Favorable Phase 2 Clinical Results with Bafetinib in Relapsed B-Cell Chronic Lymphocytic Leukemia at American Society of Hematology Conference

December 12, 2011
·
1 min read
Deals

Laboratory Corporation of America Holdings (LabCorp) Successfully Completes Tender Offer for Orchid Cellmark and Commences Subsequent Offering Period to Allow for Additional Tenders

December 12, 2011
·
1 min read
BioMidwest

Meridian Bioscience, Inc. Receives FDA Clearance for New Molecular Test: illumigene® Group B Streptococcus

December 12, 2011
·
6 min read
Drug Development

Micromet’s Blinatumomab Produces Durable Responses in Patients with Relapsed Diffuse Large B Cell Lymphoma Patients

December 12, 2011
·
1 min read